62 results
Transcatheter aortic valve replacement with self-expanding ACURATE neo2
20 Jun 2022
This study investigated the short-term safety and efficacy of the new valve ACURATE neo2 in comparison to the first neo model in a real-world population.
Reviewer
Reviewer
Prognostic impact of extra–mitral valve cardiac involvement in patients with primary mitral regurgitation
17 Jun 2022
This report builds up the evidence on the relevance of extra-valvular cardiac damage staging / involvement as a main predictor of adverse events in patients with VHD undergoing intervention, either surgical or percutaneous.
Reviewer
Reviewer
Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial
16 Jun 2022
The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.
Reviewer
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE Neo2
09 Jun 2022
The ACURATE neo2 valve was developed to reduce the risk of paravalvular AR with an increased sealing skirt. This retrospective study aimed to compare TAVI with the ACURATE neo and neo2 devices.
Reviewer
Reviewer
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial
01 Jun 2022
The present study aimed at investigating a potential reduction of the HF hospitalization rate between 1 and 2 years after inclusion in the MITRA-FR trial.
Reviewer
Reviewer
Evolution and prognostic impact of cardiac damage after aortic valve replacement
24 May 2022
The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.
Reviewer
Balloon- versus self-expanding valve systems for treating small failed surgical aortic bioprostheses: the LYTEN trial
23 May 2022
Luigi provides us with the interventional cardiologist's point of view!
Currently, TAVR selection process is performed by matching the internal diameter of the surgically implanted bioprostheses to the external diameter of commercially available TAVR devices. Nonetheless, the impact of intrinsic design differences, such as supra vs intra-annular design,...
Reviewer
EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease
22 May 2022
Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!
Author
Transcaval versus transaxillary TAVR in contemporary practice - a propensity-weighted analysis
09 May 2022
As there has been no systematic comparison of transcaval and transaxillary access so far, the present study aimed to compare these two approaches with each other, as well as with transfemoral access.
Reviewer
Reviewer
Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair
10 Feb 2022
The authors hypothesized that disordered right ventricular to pulmonary artery (RV-PA) coupling may denote RV decompensation in patients undergoing transcatheter tricuspid valve repair (TTVR) that may correlate with poor clinical outcomes.
Reviewer
Reviewer
